Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
800
NCT05037825
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Phase: N/A
Role: Lead Sponsor
Start: Nov 22, 2021
Completion: Sep 14, 2028